Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The Turbuhaler].

G Braunstein1

  • 1Laboratoires Astra-France, Nanterre.

Revue Des Maladies Respiratoires
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Metered-dose inhalers have environmental and usability issues. The Turbuhaler offers an easier-to-use alternative with equivalent terbutaline efficacy, addressing common inhalation technique errors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Testosterone therapy in women: a review.

International journal of impotence research·2005
Same author

[Optimization of asthma control with fluticasone/salmeterol (seretide) combination: new clinical data].

Revue de pneumologie clinique·2002
Same author

Evidence for multidrug resistance-1 P-glycoprotein-dependent regulation of cellular ATP permeability.

The Journal of membrane biology·2001
Same author

The pressurized metered dose inhaler (pMDI) remains the most commonly prescribed device for the delivery of inhaled asthma medications.

Respiratory medicine·2000
Same author

[Research on inflammatory mediators in asthma: new therapeutic approaches].

Therapie·2000
Same author

What internists need to know: core competencies in women's health. ABIM Subcommittee on Clinical Competence in Women's Health.

The American journal of medicine·1997
Same journal

[French version of the guidelines for connective tissue disease-associated ILD].

Revue des maladies respiratoires·2026
Same journal

[Pulmonary expression of an asymptomatic lysosomal storage disorder].

Revue des maladies respiratoires·2026
Same journal

[Factors associated with FEV1 evolution in cystic fibrosis patients treated by CFTR modulator tritherapy].

Revue des maladies respiratoires·2026
Same journal

[Subacute pulmonary coccidioidomycosis: A differential diagnosis of lung cancer].

Revue des maladies respiratoires·2026
Same journal

[Relevance of the ACT score in severe asthma with obesity: A pilot study].

Revue des maladies respiratoires·2026
Same journal

[Automated analysis of mandibular movements for the screening of obstructive sleep apnea].

Revue des maladies respiratoires·2026
See all related articles

Area of Science:

  • Respiratory medicine
  • Pharmaceutical technology
  • Environmental science

Background:

  • Metered-dose inhalers (MDIs) utilize fluorocarbons, contributing to ozone depletion.
  • MDIs can induce adverse effects like cough and bronchospasm.
  • High rates of user error (30-70%) are associated with MDI handling, primarily inhalation-actuation incoordination.

Purpose of the Study:

  • To introduce the Turbuhaler as an alternative inhalation device.
  • To evaluate the ease of use and efficacy of the Turbuhaler compared to MDIs.

Main Methods:

  • Description of the Turbuhaler's design and mechanism of action.
  • Review of studies comparing the efficacy of terbutaline delivered via Turbuhaler and MDI.
  • Assessment of user-friendliness and error rates associated with the Turbuhaler.

Related Experiment Videos

Main Results:

  • Turbuhaler demonstrates equivalent terbutaline efficacy (mg/mg) compared to MDIs.
  • Studies indicate Turbuhaler is significantly easier to use than traditional MDIs.
  • The device design potentially mitigates common MDI handling errors.

Conclusions:

  • The Turbuhaler presents a viable alternative to MDIs, addressing environmental concerns and user-related challenges.
  • Its ease of use may improve patient adherence and therapeutic outcomes.
  • Further research could explore long-term comparative effectiveness and patient satisfaction.